{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:32:42Z","timestamp":1793424762852,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s10067-026-08397-0","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:37:42Z","timestamp":1790073462000},"page":"6871-6879","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical features and prognostic factors of hospitalized patients with acute exacerbation of interstitial lung disease secondary to dermatomyositis\/polymyositis"],"prefix":"10.1007","volume":"45","author":[{"given":"Cuirong","family":"Ba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunguo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3012-8008","authenticated-orcid":false,"given":"Qiuhong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"8397_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-026-08034-w","author":"Y Zhang","year":"2026","unstructured":"Zhang Y, Du Y, Wang M, Long Y (2026) Association of malnutrition with in-hospital outcomes among patients hospitalized with dermatomyositis or polymyositis. Clin Rheumatol. https:\/\/doi.org\/10.1007\/s10067-026-08034-w","journal-title":"Clin Rheumatol"},{"issue":"9","key":"8397_CR2","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/ddg.14267","volume":"18","author":"N Schlecht","year":"2020","unstructured":"Schlecht N, Sunderk\u00f6tter C, Niehaus S, Nashan D (2020) Update on dermatomyositis in adults. J Dtsch Dermatol Ges 18(9):995\u20131013. https:\/\/doi.org\/10.1111\/ddg.14267","journal-title":"J Dtsch Dermatol Ges"},{"issue":"2","key":"8397_CR3","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jaad.2019.06.1309","volume":"82","author":"ME DeWane","year":"2020","unstructured":"DeWane ME, Waldman R, Lu J (2020) Dermatomyositis: clinical features and pathogenesis. J Am Acad Dermatol 82(2):267\u2013281. https:\/\/doi.org\/10.1016\/j.jaad.2019.06.1309","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"8397_CR4","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.autrev.2014.05.009","volume":"13","author":"D Poddighe","year":"2014","unstructured":"Poddighe D, Cavagna L, Brazzelli V, Bruni P, Marseglia GL (2014) A hyper-ferritinemia syndrome evolving in recurrent macrophage activation syndrome, as an onset of amyopathic juvenile dermatomyositis: a challenging clinical case in light of the current diagnostic criteria. Autoimmun Rev 13(11):1142\u20131148. https:\/\/doi.org\/10.1016\/j.autrev.2014.05.009","journal-title":"Autoimmun Rev"},{"key":"8397_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.rmed.2016.10.019","volume":"121","author":"H Hozumi","year":"2016","unstructured":"Hozumi H, Fujisawa T, Nakashima R et al (2016) Comprehensive assessment of myositis-specific autoantibodies in polymyositis\/dermatomyositis-associated interstitial lung disease. Respir Med 121:91\u201399. https:\/\/doi.org\/10.1016\/j.rmed.2016.10.019","journal-title":"Respir Med"},{"issue":"1","key":"8397_CR6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.amjms.2017.07.013","volume":"355","author":"F Chen","year":"2018","unstructured":"Chen F, Li S, Wang T, Shi J, Wang G (2018) Clinical heterogeneity of interstitial lung disease in polymyositis and dermatomyositis patients with or without specific autoantibodies. Am J Med Sci 355(1):48\u201353. https:\/\/doi.org\/10.1016\/j.amjms.2017.07.013","journal-title":"Am J Med Sci"},{"issue":"3","key":"8397_CR7","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1093\/rheumatology\/keaa372","volume":"60","author":"S Li","year":"2021","unstructured":"Li S, Sun Y, Shao C et al (2021) Prognosis of adult idiopathic inflammatory myopathy-associated interstitial lung disease: a retrospective study of 679 adult cases. Rheumatology (Oxford) 60(3):1195\u20131204. https:\/\/doi.org\/10.1093\/rheumatology\/keaa372","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"8397_CR8","doi-asserted-by":"publisher","first-page":"935","DOI":"10.3899\/jrheum.180825","volume":"46","author":"T Fujisawa","year":"2019","unstructured":"Fujisawa T, Hozumi H, Yasui H et al (2019) Clinical significance of serum chitotriosidase level in anti-MDA5 antibody-positive dermatomyositis-associated interstitial lung disease. J Rheumatol 46(8):935\u2013942. https:\/\/doi.org\/10.3899\/jrheum.180825","journal-title":"J Rheumatol"},{"issue":"5","key":"8397_CR9","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/art.21023","volume":"52","author":"S Sato","year":"2005","unstructured":"Sato S, Hirakata M, Kuwana M et al (2005) Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum 52(5):1571\u20131576. https:\/\/doi.org\/10.1002\/art.21023","journal-title":"Arthritis Rheum"},{"key":"8397_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/ajrccm\/aamag363","author":"YH Khor","year":"2026","unstructured":"Khor YH, Luppi F, Adegunsoye A et al (2026) Acute exacerbation in fibrotic interstitial lung disease: an International Working Group Report. Am J Respir Crit Care Med. https:\/\/doi.org\/10.1093\/ajrccm\/aamag363","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"8397_CR11","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tj\u00e4rnlund A, Bottai M et al (2017) 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis 76(12):1955\u20131964. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211468","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"8397_CR12","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/art.41105","volume":"72","author":"H Tsuji","year":"2020","unstructured":"Tsuji H, Nakashima R, Hosono Y et al (2020) Multicenter prospective study of the efficacy and safety of combined immunosuppressive therapy with high-dose glucocorticoid, tacrolimus, and cyclophosphamide in interstitial lung diseases accompanied by anti-melanoma differentiation-associated gene 5-positive dermatomyositis. Arthritis Rheumatol 72(3):488\u2013498. https:\/\/doi.org\/10.1002\/art.41105","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"8397_CR13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10067-015-3139-z","volume":"35","author":"Y Xu","year":"2016","unstructured":"Xu Y, Yang CS, Li YJ et al (2016) Predictive factors of rapidly progressive-interstitial lung disease in patients with clinically amyopathic dermatomyositis. Clin Rheumatol 35(1):113\u2013116. https:\/\/doi.org\/10.1007\/s10067-015-3139-z","journal-title":"Clin Rheumatol"},{"issue":"10","key":"8397_CR14","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1093\/rheumatology\/keh723","volume":"44","author":"EH Kang","year":"2005","unstructured":"Kang EH, Lee EB, Shin KC et al (2005) Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis. Rheumatology (Oxford) 44(10):1282\u20131286. https:\/\/doi.org\/10.1093\/rheumatology\/keh723","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"8397_CR15","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1183\/09031936.06.00038806","volume":"28","author":"T Suda","year":"2006","unstructured":"Suda T, Fujisawa T, Enomoto N et al (2006) Interstitial lung diseases associated with amyopathic dermatomyositis. Eur Respir J 28(5):1005\u20131012. https:\/\/doi.org\/10.1183\/09031936.06.00038806","journal-title":"Eur Respir J"},{"key":"8397_CR16","doi-asserted-by":"publisher","DOI":"10.1177\/17534666241250332","volume":"18","author":"C Ba","year":"2024","unstructured":"Ba C, Jiang C, Wang H, Shi X, Jin J, Fang Q (2024) Prognostic value of serum oncomarkers for patients hospitalized with acute exacerbation of interstitial lung disease. Ther Adv Respir Dis 18:17534666241250332. https:\/\/doi.org\/10.1177\/17534666241250332","journal-title":"Ther Adv Respir Dis"},{"issue":"7","key":"8397_CR17","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1002\/art.24631","volume":"60","author":"TJ Richards","year":"2009","unstructured":"Richards TJ, Eggebeen A, Gibson K et al (2009) Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease. Arthritis Rheum 60(7):2183\u20132192. https:\/\/doi.org\/10.1002\/art.24631","journal-title":"Arthritis Rheum"},{"issue":"136","key":"8397_CR18","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1183\/16000617.00002015","volume":"24","author":"JC Lega","year":"2015","unstructured":"Lega JC, Reynaud Q, Belot A, Fabien N, Durieu I, Cottin V (2015) Idiopathic inflammatory myopathies and the lung. Eur Respir Rev 24(136):216\u2013238. https:\/\/doi.org\/10.1183\/16000617.00002015","journal-title":"Eur Respir Rev"},{"issue":"3","key":"8397_CR19","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1164\/rccm.201604-0801CI","volume":"194","author":"HR Collard","year":"2016","unstructured":"Collard HR, Ryerson CJ, Corte TJ et al (2016) Acute exacerbation of idiopathic pulmonary fibrosis. An International Working Group Report. Am J Respir Crit Care Med 194(3):265\u2013275. https:\/\/doi.org\/10.1164\/rccm.201604-0801CI","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"8397_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2023-001997","volume":"11","author":"C Ba","year":"2024","unstructured":"Ba C, Wang H, Jiang C, Shi X, Jin J, Fang Q (2024) Clinical manifestations and prognostic factors analysis of patients hospitalised with acute exacerbation of idiopathic pulmonary fibrosis and other interstitial lung diseases. BMJ Open Respir Res 11(1):e001997. https:\/\/doi.org\/10.1136\/bmjresp-2023-001997","journal-title":"BMJ Open Respir Res"},{"issue":"7","key":"8397_CR21","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1093\/rheumatology\/keq073","volume":"49","author":"T Gono","year":"2010","unstructured":"Gono T, Kawaguchi Y, Hara M et al (2010) Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis. Rheumatology (Oxford) 49(7):1354\u20131360. https:\/\/doi.org\/10.1093\/rheumatology\/keq073","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"8397_CR22","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1007\/s10067-011-1840-0","volume":"30","author":"KH Yu","year":"2011","unstructured":"Yu KH, Wu YJ, Kuo CF et al (2011) Survival analysis of patients with dermatomyositis and polymyositis: analysis of 192 Chinese cases. Clin Rheumatol 30(12):1595\u20131601. https:\/\/doi.org\/10.1007\/s10067-011-1840-0","journal-title":"Clin Rheumatol"},{"issue":"11","key":"8397_CR23","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1002\/art.1780291109","volume":"29","author":"ML Christensen","year":"1986","unstructured":"Christensen ML, Pachman LM, Schneiderman R, Patel DC, Friedman JM (1986) Prevalence of Coxsackie B virus antibodies in patients with juvenile dermatomyositis. Arthritis Rheum 29(11):1365\u20131370. https:\/\/doi.org\/10.1002\/art.1780291109","journal-title":"Arthritis Rheum"},{"issue":"3","key":"8397_CR24","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/rheumatology\/kep375","volume":"49","author":"R Nakashima","year":"2010","unstructured":"Nakashima R, Imura Y, Kobayashi S et al (2010) The RIG-I-like receptor IFIH1\/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody. Rheumatology (Oxford) 49(3):433\u2013440. https:\/\/doi.org\/10.1093\/rheumatology\/kep375","journal-title":"Rheumatology (Oxford)"},{"key":"8397_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.791348","volume":"12","author":"G Wang","year":"2021","unstructured":"Wang G, Wang Q, Wang Y et al (2021) Presence of anti-MDA5 antibody and its value for the clinical assessment in patients with COVID-19: a retrospective cohort study. Front Immunol 12:791348. https:\/\/doi.org\/10.3389\/fimmu.2021.791348","journal-title":"Front Immunol"},{"issue":"21","key":"8397_CR26","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3238\/arztebl.2019.0377","volume":"116","author":"B Jany","year":"2019","unstructured":"Jany B, Welte T (2019) Pleural effusion in adults-etiology, diagnosis, and treatment. Dtsch Arztebl Int 116(21):377\u2013386. https:\/\/doi.org\/10.3238\/arztebl.2019.0377","journal-title":"Dtsch Arztebl Int"},{"issue":"2","key":"8397_CR27","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/ar2139","volume":"9","author":"C Grundtman","year":"2007","unstructured":"Grundtman C, Malmstr\u00f6m V, Lundberg IE (2007) Immune mechanisms in the pathogenesis of idiopathic inflammatory myopathies. Arthritis Res Ther 9(2):208. https:\/\/doi.org\/10.1186\/ar2139","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"8397_CR28","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2174\/187153006779025775","volume":"6","author":"H Kameda","year":"2006","unstructured":"Kameda H, Takeuchi T (2006) Recent advances in the treatment of interstitial lung disease in patients with polymyositis\/dermatomyositis. Endocr Metab Immune Disord Drug Targets 6(4):409\u2013415. https:\/\/doi.org\/10.2174\/187153006779025775","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"12","key":"8397_CR29","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s12519-024-00854-7","volume":"20","author":"K Dossybayeva","year":"2024","unstructured":"Dossybayeva K, Zhubanova G, Mussayeva A et al (2024) Nonspecific increase of \u03b1\u03b2TCR+ double-negative T cells in pediatric rheumatic diseases. World J Pediatr 20(12):1283\u20131292. https:\/\/doi.org\/10.1007\/s12519-024-00854-7","journal-title":"World J Pediatr"},{"key":"8397_CR30","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.molimm.2021.01.014","volume":"132","author":"Y Qin","year":"2021","unstructured":"Qin Y, Wang Y, Wu Y et al (2021) Double-negative T cells are absolutely elevated in patients with antineutrophil cytoplasmic autoantibody-associated vasculitis. Mol Immunol 132:250\u2013259. https:\/\/doi.org\/10.1016\/j.molimm.2021.01.014","journal-title":"Mol Immunol"},{"key":"8397_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12010166","author":"D Poddighe","year":"2024","unstructured":"Poddighe D, Dossybayeva K, Kozhakhmetov S, Rozenson R, Assylbekova M (2024) Double-negative T (DNT) cells in patients with systemic lupus erythematosus. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines12010166","journal-title":"Biomedicines"},{"issue":"4","key":"8397_CR32","doi-asserted-by":"publisher","first-page":"192","DOI":"10.4081\/reumatismo.2013.192","volume":"65","author":"A Alunno","year":"2013","unstructured":"Alunno A, Bistoni O, Bartoloni Bocci E et al (2013) IL-17-producing double-negative T cells are expanded in the peripheral blood, infiltrate the salivary gland and are partially resistant to corticosteroid therapy in patients with Sj\u00f6gren\u2019s syndrome. Reumatismo 65(4):192\u2013198. https:\/\/doi.org\/10.4081\/reumatismo.2013.192","journal-title":"Reumatismo"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08397-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08397-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08397-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:05:39Z","timestamp":1793423139000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08397-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["8397"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08397-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"assertion":[{"value":"23 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The need for informed consent was waived by the Ethics Committee of Beijing Chao-Yang Hospital because of the retrospective nature of the study.","order":1,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":3,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}